2017
DOI: 10.1016/j.meegid.2017.11.009
|View full text |Cite
|
Sign up to set email alerts
|

Host genetics and dengue fever

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
34
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 42 publications
(34 citation statements)
references
References 131 publications
0
34
0
Order By: Relevance
“…Regionspecific differences in patterns of care-seeking and criteria for hospitalization likely exist and may bias our comparisons; for example, individuals in Thailand may have been less likely to seek care for milder dengue illnesses as compared to individuals in Ecuador, and/or more likely to be hospitalized for a given clinical presentation. It is likely that human immunogenetic differences influence the clinical outcome to DENV infection and will differ across populations (29). Finally, undetected parasitic co-infections may play a role in modulating the immune response and thus the clinical outcome of DENV infection (30); for example, it is possible (but currently untested) that helminthic infections are more common in Ecuador than in Thailand and/or other parasitic co-infections such as Trypanosoma cruzi in the Americas may shape the clinical outcome of DENV infection.…”
Section: **mentioning
confidence: 99%
“…Regionspecific differences in patterns of care-seeking and criteria for hospitalization likely exist and may bias our comparisons; for example, individuals in Thailand may have been less likely to seek care for milder dengue illnesses as compared to individuals in Ecuador, and/or more likely to be hospitalized for a given clinical presentation. It is likely that human immunogenetic differences influence the clinical outcome to DENV infection and will differ across populations (29). Finally, undetected parasitic co-infections may play a role in modulating the immune response and thus the clinical outcome of DENV infection (30); for example, it is possible (but currently untested) that helminthic infections are more common in Ecuador than in Thailand and/or other parasitic co-infections such as Trypanosoma cruzi in the Americas may shape the clinical outcome of DENV infection.…”
Section: **mentioning
confidence: 99%
“…The vast majority of genetic studies for dengue have been candidate gene studies, where a number of genetic variants, including single nucleotide polymorphisms and HLA polymorphisms, have been implicated as genetic risk factors [12À19]. Existing data have been conflicting [20]. There has only been one genome-wide association study (GWAS) conducted for dengue, which showed an association between variants in major histocompatibility complex (MHC) class I polypeptide-related sequence B (MICB) and phospholipase C, epsilon 1 (PLCE1) and DSS [21].…”
Section: Introductionmentioning
confidence: 99%
“… 1 , 5 Therefore, disease severity is a complex phenomenon and depends on numerous interactions between human genetic and immunological characteristics as well as viral factors. 1 , 6 , 7 …”
mentioning
confidence: 99%
“…The influence of the host genetic background in susceptibility to severe dengue has been evidenced for different populations using either candidate genes or genome-wide approaches. 6 A genome-wide association study has reported the association between MICB and PLCE genes and dengue shock syndrome in children from Vietnam. 8 Moreover, dengue outcomes have already been associated to HLA alleles as well as genes encoding the cell receptor DC-SIGN, CLEC5A , Fc receptors, and molecules such as CTLA-4, TGF-β and MBL-2.…”
mentioning
confidence: 99%
See 1 more Smart Citation